Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine Sulfate Ophthalmic Solution for Epiphora
NCT07676981Phase 2Completed
- Start
- Jun 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of NVK002 in epiphora. Started Jun 2026; status: completed.
02
Drugs
NVK002
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT07676981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07676981.